Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-World Study of Pyrotinib Maleate in the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer With Rare Mutations in HER2

NCT05411276 is registered in ClinicalTrials.gov with Beijing Chest Hospital as lead sponsor.

NCT NCT05411276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05411276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-World Study of Pyrotinib Maleate in the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer With Rare Mutations in HER2
Lead sponsor
Beijing Chest Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2022
Completion date
December 31, 2024
Enrollment
15 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

her2 mutant non-small cell lung cancer